BIOT.STBIOT.STSTO
Loading
| Metric | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +32.96% | +23.23% | +9.13% | -9.49% | -19.79% |
| Gross Profit Growth | +37.73% | +27.56% | +7.45% | -8.40% | -20.13% |
| EBITDA Growth | +40.00% | +58.54% | -2.63% | +11.00% | -75.00% |
| Operating Income Growth | +40.74% | +61.54% | +0.00% | +15.13% | -115.79% |
| Net Income Growth | -23.26% | +41.18% | +18.42% | +21.37% | -87.88% |
| EPS Growth | -36.92% | +22.45% | +16.67% | +21.34% | -87.80% |
| EPS Diluted Growth | -36.92% | +22.45% | +19.15% | +20.73% | -87.80% |
| Weighted Average Shares Growth | +21.25% | +15.23% | +0.08% | +0.05% | +0.05% |
| Weighted Average Shares Diluted Growth | +20.98% | +15.03% | -0.01% | +0.11% | +0.15% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +881.82% | -33.33% | +5.83% | +5.19% | -60.19% |
| Free Cash Flow Growth | +0.00% | -127.27% | -23.75% | +1.63% | -83.58% |
| Receivables Growth | +18.95% | +0.25% | -100.00% | -1.04% | -15.11% |
| Inventory Growth | +46.69% | +8.94% | -100.00% | +4.81% | -0.90% |
| Asset Growth | +117.91% | -3.16% | -2.72% | +3.51% | -8.53% |
| Book Value per Share Growth | +90.01% | -12.22% | +3.20% | +12.41% | -1.16% |
| Debt Growth | +200.00% | +17.65% | -38.73% | -60.13% | -63.77% |
| R&D Expense Growth | +53.57% | +21.62% | -6.82% | +4.08% | +0.00% |
| SG&A Expenses Growth | +42.45% | +24.54% | +14.12% | +2.54% | +2.53% |